Manoj Mohan, DO
Physical Medicine and Rehabilitation · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 26
- 7 carriers
- Offices
- 3
Offices
3 locations · Golden State Orthopedics and Spine · 186 clinicians in this group
Looking this up.
Hospitals listed: Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
26 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mohan’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
26 of 26 plans
| Aetna Medicare Eagle (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
| Aetna Medicare Enhanced (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$162,358
Medicare paid this office $162,358 for 383 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 184 | $43,435 | $123 |
| New patient visit (45+ min) | 261 | $40,255 | $154 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 47 | $15,681 | $285 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 78 | $10,011 | $116 |
| Mri scan of lower spinal canal without contrast | 44 | $6,474 | $141 |
See all 14 services
| Return visit (30+ min) | 184 | $43,435 | $123 |
| New patient visit (45+ min) | 261 | $40,255 | $154 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 47 | $15,681 | $285 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 78 | $10,011 | $116 |
| Mri scan of lower spinal canal without contrast | 44 | $6,474 | $141 |
| Short return visit (20+ min) | 46 | $4,569 | $88 |
| Nerve test | 22 | $3,899 | $177 |
| Muscle electrical test | 30 | $3,046 | $92 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 18 | $2,287 | $114 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 11 | $1,978 | $116 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 33 | $1,565 | $46 |
| Nerve test | 11 | $1,309 | $119 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 11 | $1,065 | $63 |
| X-ray of lower and sacral spine, minimum of 4 views | 12 | $685 | $53 |
Who their Medicare patients are
383 Original Medicare patients in 2024. Average age 76 · Under 65 4% · 85 and older 15% · Women 59% · Also on Medicaid 9% · Health risk score 1.17. At or below the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 1.53.
Conditions among them: High blood pressure 71% · Coronary heart disease 29% · Diabetes 25% · Depression 19% · Chronic kidney disease 16% · Atrial fibrillation 16% · Cancer 15% · Heart failure 14% · COPD 10% · Stroke 9% · Dementia 5%.
The office billed $656,425, Medicare allowed $205,778 and paid $162,358; for 2,484 services of 55 kinds; $447 of it was for drugs given in the office and $161,911 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 383 | 2,484 | 76 | 1.17 | $656,425 | $162,358 |
| 2023 | 273 | 682 | 75 | 0.91 | $418,765 | $74,749 |
| 2022 | 230 | 587 | 75 | 0.86 | $308,913 | $59,693 |
| 2021 | 144 | 212 | 76 | 1.21 | $97,185 | $20,433 |
| 2020 | 45 | 51 | 68 | 1.76 | $20,041 | $3,662 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Return visit (30+ min) | 138 | $23,370 | $114 |
| New patient visit (45+ min) | 152 | $22,761 | $150 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 40 | $4,891 | $102 |
| Long return visit (40+ min) | 24 | $3,904 | $156 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 25 | $3,827 | $101 |
| Short return visit (20+ min) | 36 | $3,329 | $88 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 12 | $2,841 | $237 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 25 | $2,153 | $57 |
| New patient visit (60+ min) | 11 | $2,122 | $193 |
| New patient visit (30+ min) | 11 | $1,190 | $108 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 13 | $1,019 | $78 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 12 | $849 | $71 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 16 | $743 | $41 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 25 | $282 | $10 |
2022: 8 services
| Return visit (30+ min) | 94 | $16,938 | $119 |
| New patient visit (45+ min) | 109 | $16,087 | $148 |
| New patient visit (30+ min) | 61 | $5,915 | $97 |
| Short return visit (20+ min) | 55 | $5,372 | $81 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 33 | $3,982 | $102 |
| Long return visit (40+ min) | 12 | $1,853 | $154 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 20 | $1,716 | $86 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 23 | $273 | $11 |
2021: 6 services
| New patient visit (45+ min) | 34 | $5,307 | $156 |
| New patient visit (30+ min) | 28 | $2,527 | $90 |
| Return visit (30+ min) | 19 | $2,486 | $124 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 20 | $1,846 | $92 |
| Short return visit (20+ min) | 19 | $1,682 | $76 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,445 | $66 |
2020: 1 service
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 18 | $1,674 | $93 |
Drugs they prescribed that Part D paid
$808
Pharmacies billed $808 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 20% of their Part D prescriptions (20 of 99) in 2024. Above the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 12%.
99 generic and 0 brand-name prescriptions · $808 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 11 | $187 | $17 |
| Gabapentin | 27 | $167 | $6 |
| Meloxicam | 23 | $73 | $3 |
Year by year
| 2024 | 99 | 48 | 20% (20) | 0% | $808 |
| 2023 | 30 | 16 | 0% (0) | 0% | $110 |
| 2022 | 40 | 26 | 0% (0) | 0% | $318 |
| 2021 | 37 | 21 | 0% (0) | 0% | $421 |
| 2018 | 182 | 29 | 0% (0) | None | $8,773 |
| 2017 | 77 | 14 | 0% (0) | None | $2,619 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Gabapentin | 14 | $66 | $5 |
2022: 1 drug
| Cyclobenzaprine | 16 | $114 | $7 |
2021: 2 drugs
| Gabapentin | 13 | $195 | $15 |
| Cyclobenzaprine | 11 | $85 | $8 |
2018: 1 drug
| Atorvastatin | 14 | $175 | $12 |
Money from drug and device companies
$112 in 2025
| 2025 | 2 | 2 | None | $112 |
| 2024 | 2 | 7 | None | $747 |
| 2023 | 1 | 3 | None | $362 |
| 2022 | 1 | 2 | None | $54 |
| 2021 | 1 | 2 | None | $44 |
| 2020 | 1 | 2 | None | $35 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| SPR Therapeutics | Sprint Pns System | $83 | 1 payment
|
| Amgen | Evenity | $29 | 1 payment
|
See all 2 published payments
| Amgen | Meals · 2025-08-05 | Evenity | $29 |
| SPR Therapeutics | Meals · 2025-03-29 | Sprint Pns System | $83 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $747
| Boston Scientific | Wavewriter Alpha Prime 16 | $721 | 6 payments
|
| Si-Bone | None | $26 | 1 payment
|
2023: $362
| SPR Therapeutics | Sprint Pns System | $362 | 3 payments
|
2022: $54
| Relievant Medsystems | Intracept | $54 | 2 payments
|
2021: $44
| Relievant Medsystems | Intracept | $44 | 2 payments
|
2020: $35
| Medtronic USA | Kyphon Balloon Kyphoplasty | $35 | 2 payments
|
Professional record
- NPI
- 1346603529
- Licence
- CA 20A16543
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 208100000X (208100000X)
- Mailing address
- Po Box 31396, Walnut Creek, CA, 94598
- NPI first listed
- 2016-04-04
- NPI last updated
- 2023-11-16
- NPI record certified
- 2023-11-16
This is when the NPI record was last certified, not a medical board exam.